Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trial

Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trial

Background The influence of sex on treatment outcomes during interleukin-12/23 therapy in patients with psoriatic arthritis (PsA) has not been explored.Objective To conduct exploratory post hoc analyses of sex-stratified data from the MUST trial, an investigator-initiated, multicentre, phase 3b stud...

Full description

Bibliographic Details
Main Authors: Frank Behrens, Jürgen Rech, Jürgen Braun, Denis Poddubnyy, Gerd R Burmester, Uta Kiltz, Stephanie Finzel, Diamant Thaçi, Herbert Kellner, Karolina Benesova, Reinhard E Voll, Jan Brandt, Andrea Rubbert-Roth, David M Kofler, Klaus Krüger, Siegfried Wassenberg, Winfried Demary, Regina Max, Peter Kastner, Michaela Koehm, Ulrich von Hinüber, Raoul Bergner, Jan Brandt-Jürgens, Ann C Foldenauer, Tanja Rossmanith, Maren Sieburg, Rieke HE Alten, Arnd Kleye, David Kofler, Gabriele Lorenz, Holger Schwenke, Astrid Thiele, Jochen Walter
Format: Article
Language:English
Published: BMJ Publishing Group 2023-10-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/9/4/e003538.full

Internet

https://rmdopen.bmj.com/content/9/4/e003538.full

Similar Items